Fulcrum Therapeutics, Inc. (FULC) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 716.55M |
| Enterprise Value | 525.46M |
| P/E Ratio | -3.14 |
| PEG Ratio | -8.29 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.93 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.18 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.26 |
| Return On Equity | -0.29 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1.39M |
| EBITDA | -73.49M |
| Net Income | -74.88M |
| Diluted EPS | -1.18 |
Balance Sheet
| Total Cash | 318.84M |
| Total Cash/Share | 4.18 |
| Total Debt | 5.28M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 31.35 |
| Book Value Per Share | 4.07 |
Price History
| 52-Week Change | -45.71 |
| 52-Week High | 15.74 |
| 52-Week Low | 2.83 |
| Moving Average 50 Days | 3.75 |
| Moving Average 200 Days | 7.22 |
Statistics
| Average Volume | 2.11M |
| Shares Outstanding | 76.3M |
| % Held by Institutions | 104.8 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
